Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.737
-0.084 (-4.59%)
Oct 10, 2025, 12:09 PM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
Human Pharmaceutical Products
266.96M
Log In
Log In
Log In
Log In
Upgrade
Human Pharmaceutical Products Growth
3.78%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
United States
266.96M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
3.78%
Log In
Log In
Log In
Log In
Upgrade